Drug profile · INN
berdazimer sodium
ZELSUVMI
berdazimer sodium (ZELSUVMI) is a releases no, antimicrobial. Route of administration: topical. Current US regulatory status: approved.
Drug details — berdazimer sodium
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
berdazimer sodium (ZELSUVMI) is a releases no, antimicrobial. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Releases NO, antimicrobial
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is berdazimer sodium?
berdazimer sodium (ZELSUVMI) is a releases no, antimicrobial. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for berdazimer sodium?
ZELSUVMI is a marketed brand name for berdazimer sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of berdazimer sodium?
berdazimer sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.